Avecho Biotechnology Limited (AVE) Stock Statistics & Valuation Metrics

Avecho Biotechnology Limited has a market cap or net worth of AUD 46.36M. The enterprise value is AUD 82.85M.

Market Cap

AUD 46.36M

Enterprise Value

AUD 82.85M

Avecho Biotechnology Limited has 3,863,725,800 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding

3,863,725,800

Owned by Insiders

0.28%

Owned by Institutions

―

Avecho Biotechnology Limited’s return on equity (ROE) is -2.83 and return on invested capital (ROIC) is -64.50%.

Return on Equity (ROE)

-2.83

Return on Assets (ROA)

-0.62

Return on Invested Capital (ROIC)

-64.50%

Return on Capital Employed (ROCE)

-0.94

Revenue Per Employee

137.53K

Profits Per Employee

-490.74K

Employee Count

9

Asset Turnover

0.17

Inventory Turnover

60.31

The current PE Ratio of Avecho Biotechnology Limited is -8.00. Avecho Biotechnology Limited’s PEG ratio is 0.08.

PE Ratio

-8.00

PS Ratio

45.57

PB Ratio

23.39

Price to FCF

-13.32

Price to Operating Cash Flow

-12.83

PEG Ratio

0.08

In the last 12 months, Avecho Biotechnology Limited had revenue of 1.24M and earned -4.42M in profits. Earnings per share was -0.00.

Revenue

1.24M

Gross Profit

751.29K

Operating Income

-6.00M

Pretax Income

-6.41M

Net Income

-4.42M

EBITDA

-5.87M

Earnings Per Share (EPS)

-0.00

In the last 12 months, operating cash flow was -3.48M and capital expenditures -2,000, giving a free cash flow of -3.48M billion.

Operating Cash Flow

-3.48M

Free Cash Flow

-3.48M

Free Cash Flow per Share

-0.00

Avecho Biotechnology Limited pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share

―

Dividend Yield

―

Payout Ratio

N/A

Free Cash Flow Yield

-7.51%

Earnings Yield

-8.21%

Beta

1.41

52-Week Price Change

20.00%

50-Day Moving Average

0.02

200-Day Moving Average

0.01

Relative Strength Index (RSI)

43.13

Average Volume (3m)

3.74M

Avecho Biotechnology Limited upcoming earnings date is Mar 03, 2027, TBA (Not Confirmed).

Last Earnings Date

Aug 25, 2026

Next Earnings Date

Mar 03, 2027

Ex-Dividend Date

―

Avecho Biotechnology Limited as a current ratio of 9.95, with Debt / Equity ratio of 0.93%

Current Ratio

9.95

Quick Ratio

9.94

Debt to Market Cap

0.00

Net Debt to EBITDA

0.79

Interest Coverage Ratio

-13.01

In the past 12 months, Avecho Biotechnology Limited has paid -2.00M in taxes.

Income Tax

-2.00M

Effective Tax Rate

0.31

Avecho Biotechnology Limited EV to EBITDA ratio is -5.11, with an EV/FCF ratio of -11.49.

EV to Sales

39.30

EV to EBITDA

-5.11

EV to Free Cash Flow

-11.49

EV to Operating Cash Flow

-11.49

Avecho Biotechnology Limited has AUD 6.61M in cash and marketable securities with AUD 227.54K in debt, giving a net cash position of AUD 6.38M billion.

Cash & Marketable Securities

AUD 6.61M

Total Debt

AUD 227.54K

Net Cash

AUD 6.38M

Net Cash Per Share

AUD 0.00

Tangible Book Value Per Share

AUD 0.00

Gross margin is 53.38%, with operating margin of -742.55%, and net profit margin of -360.19%.

Gross Margin

53.38%

Operating Margin

-742.55%

Pretax Margin

-822.47%

Net Profit Margin

-360.19%

EBITDA Margin

-769.36%

EBIT Margin

-781.51%

The average price target for Avecho Biotechnology Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target

―

Price Target Upside

―

Analyst Consensus

―

Analyst Count

―

Revenue Growth Forecast

-46.59%

EPS Growth Forecast

9.09%

Smart Score

3

AI Score

48